Rheumatology
Pictorial Review: Spinal disorders mimicking infection.
5 Dec, 2021 | 23:10h | UTCSpinal disorders mimicking infection – Insights into Imaging
Retrospective Cohort Study: Except for Rituximab, most immunosuppressive medicines were not associated with increased risk of mechanical ventilation or death in patients hospitalized with Covid-19.
2 Dec, 2021 | 10:07h | UTCCommentaries:
What does endemic COVID-19 mean for the future of rituximab? – The Lancet Rheumatology
Study: Immune-suppressed not at higher risk of poor COVID outcomes – CIDRAP
Commentary on Twitter
NEW RESEARCH—Long-term use of immunosuppressive medicines and in-hospital #COVID19 outcomes: data from N3C shows no increased risk of mechanical ventilation or in-hospital death with the exception of #rituximab https://t.co/vEyTzfvK5q #LancetRheumatology
@JohnsHopkins pic.twitter.com/NqlttjGrpj— The Lancet Rheumatology (@TheLancetRheum) November 16, 2021
2021 DORIS definition of remission in SLE: final recommendations from an international task force.
26 Nov, 2021 | 10:01h | UTC
The musculoskeletal manifestations of Marfan Syndrome: diagnosis, impact, and management.
28 Nov, 2021 | 20:58h | UTC
Review: A Road Map of the Axial Spondyloarthritis Continuum.
24 Nov, 2021 | 08:27h | UTCA Road Map of the Axial Spondyloarthritis Continuum – Mayo Clinic Proceedings
RCT: Tofacitinib (oral drug) is an effective treatment in patients with polyarticular course juvenile idiopathic arthritis.
21 Nov, 2021 | 22:38h | UTCTofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
NEW in @TheLancet — Tofacitinib in juvenile idiopathic #arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial
Flare rate by week 44 was significantly lower with tofacitinib (29%) than with placebo (53%) https://t.co/28JRrbPf8e #JIA pic.twitter.com/JzxHLNmgym
— The Lancet Rheumatology (@TheLancetRheum) November 10, 2021
What Is the best maintenance therapy for ANCA vasculitis?
18 Nov, 2021 | 08:34h | UTC
Review: Antineutrophil cytoplasmic antibody-associated interstitial lung disease.
10 Nov, 2021 | 06:46h | UTC
CDC Guidance: Immunocompromised may need a fourth Covid-19 shot.
4 Nov, 2021 | 10:06h | UTCCommentaries:
Immunocompromised may need a fourth Covid-19 shot, CDC says – CNN
Some immunocompromised people can receive a 4th Covid shot, CDC says – NBC News
NICE Guideline | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management.
31 Oct, 2021 | 20:03h | UTCCommentaries:
Chronic fatigue syndrome advice scraps exercise therapy – BBC
ME exercise therapy guidance scrapped by health watchdog Nice – The Guardian
RCT: Extended follow-up of local steroid injection for carpal tunnel syndrome.
28 Oct, 2021 | 09:46h | UTC
Commentary on Twitter
In carpal tunnel syndrome, this randomized trial of local steroid vs placebo injection shows similar symptom severity score improvement but a significant small reduction in rate of and longer time to surgery after steroid. @IsamAtroshi @jonasranstam https://t.co/s5LibRnFaV
— JAMA Network Open (@JAMANetworkOpen) October 22, 2021
Review: Thoracic involvement and imaging patterns in IgG4-related disease.
26 Oct, 2021 | 01:22h | UTCThoracic involvement and imaging patterns in IgG4-related disease – European Respiratory Review
Commentary on Twitter
Thoracic and lung involvement of IgG4-RD are heterogeneous and underevaluated. Peribronchovascular involvement and lymph node enlargement are most frequent patterns. Interstitial disease pattern seems to be associated with lower rate of treatment response. https://t.co/AMuLjPByut pic.twitter.com/ZmDrz6nK6g
— ERS publications (@ERSpublications) October 13, 2021
Cluster RCT: Increasing the dietary sources of calcium and protein (by providing additional milk, yogurt, and cheese) reduced hip fractures and falls in older adults in residential care.
22 Oct, 2021 | 10:21h | UTCNews release: Increasing dairy intake reduces falls and fractures among older care home residents – British Medical Journal
Commentary on Twitter
Increasing intake of foods rich in calcium and protein such as milk, yoghurt, and cheese, reduces falls and fractures in older adults living in residential care, finds a randomised controlled trial published @bmj_latest today https://t.co/QzozG4Odjb
— BMJ Group (@bmj_company) October 21, 2021
The Dutch Multidisciplinary Occupational Health Guideline to Enhance Work Participation Among Low Back Pain and Lumbosacral Radicular Syndrome Patients.
7 Oct, 2021 | 10:18h | UTC
Evidence and consensus-based recommendations for non-pharmacological treatment of fatigue, hand function loss, Raynaud’s phenomenon, and digital ulcers in patients with systemic sclerosis.
7 Oct, 2021 | 10:19h | UTC
Systematic Review: Is exercise an effective therapy to treat long-lasting low back pain?
3 Oct, 2021 | 22:32h | UTCSummary: Is exercise an effective therapy to treat long-lasting low back pain? – Cochrane Library
Original Study: Exercise therapy for chronic low back pain – Cochrane Library
Commentary on Twitter
https://twitter.com/CochraneUK/status/1444221879502483456
Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system—part V, knee.
23 Sep, 2021 | 09:59h | UTCSee other articles in the series: Consensus paper: Clinical indications for image-guided interventional procedures in the musculoskeletal system.
AAOS Updates Clinical Practice Guideline for Osteoarthritis of the Knee.
21 Sep, 2021 | 09:03h | UTCNews release: AAOS Updates Clinical Practice Guideline for Osteoarthritis of the Knee – American Academy of Orthopaedic Surgeons
Guideline summary: Management of Osteoarthritis of the Knee (Non-Arthroplasty) (3rd Edition) – American Academy of Orthopaedic Surgeons
Full paper: Management of Osteoarthritis of the Knee (Non-Arthroplasty) Evidence-Based Clinical Practice Guideline
KDIGO 2021 clinical practice guideline for the management of glomerular diseases.
21 Sep, 2021 | 09:05h | UTCExecutive summary: KDIGO 2021 Guideline for the Management of Glomerular Diseases – Kidney Disease: Improving Global Outcomes
[Preprint] RCT: Additional heterologous vs. homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination.
9 Sep, 2021 | 09:55h | UTC
Commentary on Twitter (thread – click for more)
https://twitter.com/hildabast/status/1435720202147143680
Musculoskeletal complications following critical illness: A scoping review.
3 Sep, 2021 | 10:07h | UTC
Commentary on Twitter
Very pleased that our scoping review on MSK complications following critical illness has been published – first paper from my PhD! @mawilliamsinOx @helendawes2 @matthewjrowland @ouh_therapies @MOReS_OBU #icurehab https://t.co/f6kHDtMzrj pic.twitter.com/bOm3YvLP5U
— Owen Gustafson (@OxfordICUPhysio) August 26, 2021
Role of diagnostic imaging in psoriatic arthritis: how, when, and why.
3 Sep, 2021 | 10:05h | UTCRole of diagnostic imaging in psoriatic arthritis: how, when, and why – Insights into Imaging
Review | COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses.
2 Sep, 2021 | 10:06h | UTC
Commentary on Twitter
NEW REVIEW—COVID-19 and immune-mediated inflammatory diseases
Filippo Fagni and colleagues @UniFAU review the effect of disease and treatment on #COVID19 outcomes and #vaccine responseshttps://t.co/ue8XnDF1sM #LancetRheumatology @KorayTascilar pic.twitter.com/Yrk4SmeSbE
— The Lancet Rheumatology (@TheLancetRheum) August 27, 2021
Supplement: The future of JAK1 selective inhibitors in rheumatology.
26 Aug, 2021 | 08:30h | UTCHomepage: The future of JAK1 selective inhibitors – Rheumatology
How important is JAK1 selectivity?
JAK1: Number one in the family; number one in inflammation?
Early phase studies of JAK1 selective inhibitors in rheumatoid arthritis
Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis
The safety of JAK-1 inhibitors
Clinical use of Jak 1 inhibitors for rheumatoid arthritis
JAK1 selective inhibitors for the treatment of spondyloarthropathies
JAK1 inhibition and inflammatory bowel disease
ACOG Guideline: Osteoporosis prevention, screening, and diagnosis.
22 Aug, 2021 | 23:08h | UTC